National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Sponsor: FRANK PALLONE (D-NJ)
This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA.
Health Topic assigned by the Congressional Research Service.
Who won, and how much of the country was behind them
The dotted gap is 2.6% of U.S. adults whose member did not vote, voted “present,” or whose seat was vacant.
| Side | Outcome | Votes | Share of U.S. adults |
|---|---|---|---|
| Yea | Won | 368 | 84.2% |
| Nay | Lost | 56 | 13.3% |
| Not represented on this question | No position taken | 0 | 2.6% |